Cai and colleagues show that miR-29s were differentially expressed in these two types of GC and mainly regulated the ECM-receptor interaction pathway by targeting COL4A1 to inhibit the migration and invasion of GC cells. The gene discussed is COL4A1; the disease is gastric cancer.